Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3849609 | 0.86 | TDP1 (0.60) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL14641737 | 0.85 | TDP1 (0.69) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL27645574 | 0.84 | ALDH1A1 (0.70) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL10902775 | 0.81 | TDP1 (0.64) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL715298 | 0.81 | TDP1 (0.64) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL14363082 | 0.81 | TDP1 (0.64) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL16803358 | 0.81 | TDP1 (0.64) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL3841885 | 0.81 | TDP1 (0.64) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL1067609 | 0.81 | TDP1 (0.64) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 | |
| SCHEMBL6205360 | 0.81 | TDP1 (0.64) | TSHRALDH1A1TDP1SMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307540-B | Synthesis method of avibactam sodium | 浙江尖峰药业有限公司 | 2024-10-15 | — | — | CN | claimed |
| EP-4400166-A2 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| CN-118307540-A | Synthesis method of avibactam sodium | 浙江尖峰药业有限公司 | 2024-07-09 | — | — | CN | claimed |
| EP-3565484-B1 | COMPOSITIONS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | CONTRALINE INC (US) | 2024-04-03 | — | — | EP | claimed |
| US-20220031607-A1 | INJECTION COMPOSITION CONTAINING FAB I INHIBITOR, AND PREPARATION METHOD THEREFOR | CRYSTALGENOMICS, INC. (KR) | 2022-02-03 | — | — | US | claimed |
| US-20220016098-A1 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION COMPRISING FAB I INHIBITORS AND METHOD FOR PREPARING SAME | CRYSTALGENOMICS, INC. (KR) | 2022-01-20 | — | — | US | claimed |
| EP-3915538-A1 | INJECTION COMPOSITION CONTAINING FAB I INHIBITOR, AND PREPARATION METHOD THEREFOR | Crystalgenomics, Inc. (KR) | 2021-12-01 | — | — | EP | claimed |
| CN-113613627-A | Injection composition containing Fab I inhibitor and preparation method thereof | 晶体基因技术株式会社 | 2021-11-05 | — | — | CN | claimed |
| EP-3824888-A1 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION COMPRISING FAB I INHIBITORS AND METHOD FOR PREPARING SAME | Crystalgenomics, Inc. (KR) | 2021-05-26 | — | — | EP | claimed |
| CN-112423751-A | Orally administered pharmaceutical compositions comprising Fab I inhibitors and methods of making the same | 晶体基因技术株式会社 | 2021-02-26 | — | — | CN | claimed |
| WO-2020017756-A1 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION COMPRISING FAB I INHIBITORS AND METHOD FOR PREPARING SAME | 크리스탈지노믹스(주) | 2020-01-23 | — | — | WO | claimed |
| EP-3565484-A1 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. (US) | 2019-11-13 | — | — | EP | claimed |
| WO-2018129369-A1 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. (US) | 2018-07-12 | — | — | WO | claimed |
| US-20180185096-A1 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. | 2018-07-05 | — | — | US | claimed |
| US-12383421-B2 | Contraceptive devices | Contraline, Inc. (US) | 2025-08-12 | — | — | US | disclosed |
| CN-118307540-B | Synthesis method of avibactam sodium | 浙江尖峰药业有限公司 | 2024-10-15 | — | — | CN | disclosed |
| EP-4400166-A2 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. (US) | 2024-07-17 | — | — | EP | disclosed |
| US-4165316-A | Process for preparing sulfinyl chlorides from penicillin sulfoxides | ELI LILLY AND COMPANY (US) | 1979-08-21 | — | — | US | disclosed |
| EP-0000718-A2 | Quinazoline derivatives, process for their preparation, pharmaceutical preparations and their preparation | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-02-21 | — | — | EP | disclosed |
| US-4075203-A | Process for preparing a 3-exomethylenecepham sulfoxide from penicillin sulfoxides | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220016098-A1 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION COMPRISING FAB I INHIBITORS AND METHOD FOR PREPARING SAME | FCGRT, PEF1, SI | TSHR 4334/4885ALDH1A1 4212/4885TDP1 3737/4885 |
| US-20220031607-A1 | INJECTION COMPOSITION CONTAINING FAB I INHIBITOR, AND PREPARATION METHOD THEREFOR | FAR1, NOTUM, IDE | TSHR 4448/4885ALDH1A1 3888/4885TDP1 4186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.